Beta Cell Imaging—From Pre-Clinical Validation to First in Man Testing

There are presently no reliable ways to quantify human pancreatic beta cell mass (BCM) in vivo, which prevents an accurate understanding of the progressive beta cell loss in diabetes or following islet transplantation. Furthermore, the lack of beta cell imaging hampers the evaluation of the impact o...

Descripción completa

Detalles Bibliográficos
Autores principales: Demine, Stephane, Schulte, Michael L., Territo, Paul R., Eizirik, Decio L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7582644/
https://www.ncbi.nlm.nih.gov/pubmed/33019671
http://dx.doi.org/10.3390/ijms21197274

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7582644/
https://www.ncbi.nlm.nih.gov/pubmed/33019671
http://dx.doi.org/10.3390/ijms21197274

Ejemplares similares